{"id":"https://openalex.org/W3138511673","doi":"https://doi.org/10.22270/ujpr.v6i1.536","title":"PHARMACEUTICAL EVALUATION AND POST-MARKET SURVEILLANCE STUDY OF THREE BRANDS OF LISINOPRIL TABLETS IN SUDAN","display_name":"PHARMACEUTICAL EVALUATION AND POST-MARKET SURVEILLANCE STUDY OF THREE BRANDS OF LISINOPRIL TABLETS IN SUDAN","publication_year":2021,"publication_date":"2021-03-15","ids":{"openalex":"https://openalex.org/W3138511673","doi":"https://doi.org/10.22270/ujpr.v6i1.536","mag":"3138511673"},"language":"en","primary_location":{"id":"doi:10.22270/ujpr.v6i1.536","doi":"https://doi.org/10.22270/ujpr.v6i1.536","is_oa":true,"landing_page_url":"https://doi.org/10.22270/ujpr.v6i1.536","pdf_url":"https://ujpr.org/index.php/journal/article/download/536/898","source":{"id":"https://openalex.org/S4210198516","display_name":"Universal Journal of Pharmaceutical Research","issn_l":"2456-8058","issn":["2456-8058","2831-5235"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4323972972","host_organization_name":"Society of Pharmaceutical Tecnocrats","host_organization_lineage":["https://openalex.org/P4323972972"],"host_organization_lineage_names":["Society of Pharmaceutical Tecnocrats"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Universal Journal of Pharmaceutical Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://ujpr.org/index.php/journal/article/download/536/898","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112878142","display_name":"Fatehalrahman F. Magbool","orcid":"https://orcid.org/0000-0003-0411-4120","observed_orcids":["https://orcid.org/0000-0003-0411-4120"]},"institutions":[{"id":"https://openalex.org/I224517680","display_name":"Al-Neelain University","ror":"https://ror.org/05dvsnx49","country_code":"SD","type":"education","lineage":["https://openalex.org/I224517680"]}],"countries":["SD"],"is_corresponding":false,"raw_author_name":"Fatehalrahman F. Magbool","raw_affiliation_strings":["Department of Pharmaceutics, Faculty of Pharmacy, Al-Neelain University, Khartoum, Sudan"],"raw_orcid":"https://orcid.org/0000-0003-0411-4120","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmacy, Al-Neelain University, Khartoum, Sudan","institution_ids":["https://openalex.org/I224517680"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027351531","display_name":"Abdrhman Mahmoud Gamil","orcid":"https://orcid.org/0000-0002-7010-090X","observed_orcids":["https://orcid.org/0000-0002-7010-090X"]},"institutions":[{"id":"https://openalex.org/I224517680","display_name":"Al-Neelain University","ror":"https://ror.org/05dvsnx49","country_code":"SD","type":"education","lineage":["https://openalex.org/I224517680"]}],"countries":["SD"],"is_corresponding":false,"raw_author_name":"Abdrhman Mahmoud Gamil","raw_affiliation_strings":["Department of Pharmaceutics, Faculty of Pharmacy, Al-Neelain University, Khartoum, Sudan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmacy, Al-Neelain University, Khartoum, Sudan","institution_ids":["https://openalex.org/I224517680"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063023277","display_name":"Alaa I. M. Ahmed","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I224517680","display_name":"Al-Neelain University","ror":"https://ror.org/05dvsnx49","country_code":"SD","type":"education","lineage":["https://openalex.org/I224517680"]}],"countries":["SD"],"is_corresponding":false,"raw_author_name":"Alaa I. M. Ahmed","raw_affiliation_strings":["Department of Pharmaceutics, Faculty of Pharmacy, Al-Neelain University, Khartoum, Sudan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmacy, Al-Neelain University, Khartoum, Sudan","institution_ids":["https://openalex.org/I224517680"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015530368","display_name":"Anasseya HA Hassan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I224517680","display_name":"Al-Neelain University","ror":"https://ror.org/05dvsnx49","country_code":"SD","type":"education","lineage":["https://openalex.org/I224517680"]}],"countries":["SD"],"is_corresponding":false,"raw_author_name":"Anasseya HA Hassan","raw_affiliation_strings":["Department of Pharmaceutics, Faculty of Pharmacy, Al-Neelain University, Khartoum, Sudan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmacy, Al-Neelain University, Khartoum, Sudan","institution_ids":["https://openalex.org/I224517680"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063930355","display_name":"Nagwa J. M. Ali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I224517680","display_name":"Al-Neelain University","ror":"https://ror.org/05dvsnx49","country_code":"SD","type":"education","lineage":["https://openalex.org/I224517680"]}],"countries":["SD"],"is_corresponding":false,"raw_author_name":"Nagwa J. M. Ali","raw_affiliation_strings":["Department of Pharmaceutics, Faculty of Pharmacy, Al-Neelain University, Khartoum, Sudan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmacy, Al-Neelain University, Khartoum, Sudan","institution_ids":["https://openalex.org/I224517680"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I224517680"],"apc_list":null,"apc_paid":null,"fwci":0.4109,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.59476594,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.01810000091791153,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lisinopril","display_name":"lisinopril","score":0.9539999961853027},{"id":"https://openalex.org/keywords/generic-drug-quality","display_name":"generic drug quality","score":0.7599999904632568},{"id":"https://openalex.org/keywords/tablet-quality-assessment","display_name":"tablet quality assessment","score":0.49300000071525574},{"id":"https://openalex.org/keywords/post-marketing-surveillance","display_name":"post-marketing surveillance","score":0.6790000200271606},{"id":"https://openalex.org/keywords/dissolution-rate","display_name":"dissolution rate","score":0.5059999823570251},{"id":"https://openalex.org/keywords/similarity-factor","display_name":"similarity factor","score":0.7720000147819519},{"id":"https://openalex.org/keywords/weight-uniformity","display_name":"weight uniformity","score":0.8339999914169312},{"id":"https://openalex.org/keywords/friability","display_name":"friability","score":0.718999981880188},{"id":"https://openalex.org/keywords/disintegration","display_name":"disintegration","score":0.6919999718666077},{"id":"https://openalex.org/keywords/drug-content","display_name":"drug content","score":0.824999988079071},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.8970000147819519},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.753000020980835},{"id":"https://openalex.org/keywords/sudan","display_name":"Sudan","score":0.42500001192092896},{"id":"https://openalex.org/keywords/pharmaceutical-quality-control","display_name":"pharmaceutical quality control","score":0.6159999966621399},{"id":"https://openalex.org/keywords/pharmacopoeial-specifications","display_name":"pharmacopoeial specifications","score":0.574999988079071}],"concepts":[{"id":"https://openalex.org/C2777880890","wikidata":"https://www.wikidata.org/wiki/Q412208","display_name":"Lisinopril","level":4,"score":0.931018054485321},{"id":"https://openalex.org/C191168616","wikidata":"https://www.wikidata.org/wiki/Q5503337","display_name":"Friability","level":4,"score":0.8473310470581055},{"id":"https://openalex.org/C14029885","wikidata":"https://www.wikidata.org/wiki/Q5282807","display_name":"Dissolution testing","level":4,"score":0.5414706468582153},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.4493725895881653},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3366195559501648},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33351361751556396},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3076498508453369},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2863461971282959},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.1882876753807068},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.14925891160964966},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.06393077969551086},{"id":"https://openalex.org/C2781430271","wikidata":"https://www.wikidata.org/wiki/Q278760","display_name":"Biopharmaceutics Classification System","level":3,"score":0.0},{"id":"https://openalex.org/C201253974","wikidata":"https://www.wikidata.org/wiki/Q1330121","display_name":"First pass effect","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.22270/ujpr.v6i1.536","doi":"https://doi.org/10.22270/ujpr.v6i1.536","is_oa":true,"landing_page_url":"https://doi.org/10.22270/ujpr.v6i1.536","pdf_url":"https://ujpr.org/index.php/journal/article/download/536/898","source":{"id":"https://openalex.org/S4210198516","display_name":"Universal Journal of Pharmaceutical Research","issn_l":"2456-8058","issn":["2456-8058","2831-5235"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4323972972","host_organization_name":"Society of Pharmaceutical Tecnocrats","host_organization_lineage":["https://openalex.org/P4323972972"],"host_organization_lineage_names":["Society of Pharmaceutical Tecnocrats"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Universal Journal of Pharmaceutical Research","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.22270/ujpr.v6i1.536","doi":"https://doi.org/10.22270/ujpr.v6i1.536","is_oa":true,"landing_page_url":"https://doi.org/10.22270/ujpr.v6i1.536","pdf_url":"https://ujpr.org/index.php/journal/article/download/536/898","source":{"id":"https://openalex.org/S4210198516","display_name":"Universal Journal of Pharmaceutical Research","issn_l":"2456-8058","issn":["2456-8058","2831-5235"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4323972972","host_organization_name":"Society of Pharmaceutical Tecnocrats","host_organization_lineage":["https://openalex.org/P4323972972"],"host_organization_lineage_names":["Society of Pharmaceutical Tecnocrats"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Universal Journal of Pharmaceutical Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3138511673.pdf","grobid_xml":"https://content.openalex.org/works/W3138511673.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W2034613829","https://openalex.org/W2057124956","https://openalex.org/W2068693318","https://openalex.org/W2071991867","https://openalex.org/W2098924740","https://openalex.org/W2116139441","https://openalex.org/W2192435108","https://openalex.org/W2219584673","https://openalex.org/W2740096497","https://openalex.org/W2894436659","https://openalex.org/W4255595572"],"related_works":["https://openalex.org/W6957780781","https://openalex.org/W4413843251","https://openalex.org/W7215638153","https://openalex.org/W4372348865","https://openalex.org/W4401065717","https://openalex.org/W4405996711","https://openalex.org/W4415834211","https://openalex.org/W4386000583","https://openalex.org/W199263042","https://openalex.org/W4281756061"],"abstract_inverted_index":{"Background:":[0],"Lisinopril":[1,93,114,252],"is":[2,35,146,398],"a":[3,235,322,404,415],"type":[4],"of":[5,26,64,70,90,113,151,251,287,324,375,396,403,414,457,462,471],"angiotensin-converting":[6],"enzyme":[7],"(ACE)":[8],"inhibitor":[9],"that":[10],"used":[11],"to":[12,48,74,85,148,153,207,243,295,303,359,367,385],"treat":[13],"high":[14],"blood":[15],"pressure":[16],"(hypertension)":[17],"in":[18,83,97,194,237,342,421],"adults":[19],"and":[20,24,37,53,56,76,80,107,122,126,142,183,205,242,249,278,335,378,412,424,459],"children.":[21],"The":[22,68,185,285,393],"safety":[23,248],"efficacy":[25,250],"drug":[27,120,159,226],"products":[28,51],"can":[29],"be":[30,208,293,357],"assured":[31],"when":[32],"their":[33,50,332,338,364,376,382],"quality":[34,89,241,402],"consistent":[36],"reproducible.":[38],"To":[39],"ensure":[40],"the":[41,61,65,78,87,91,104,144,154,170,175,214,222,239,275,288,343,368,386,401,410,422],"requisite":[42],"quality,":[43,247],"pharmaceutical":[44,81,88,108,240],"companies":[45],"are":[46,340],"required":[47],"test":[49],"during":[52,60,318],"after":[54],"manufacturing":[55],"at":[57,434,442],"various":[58],"intervals":[59],"shelf":[62],"life":[63],"product.":[66],"Methods:":[67],"aim":[69],"this":[71,230,325],"study":[72,75,231],"was":[73,100],"evaluate":[77],"physicochemical":[79,106],"parameters":[82],"order":[84],"confirm":[86],"generic":[92,155],"tablet":[94,253],"formulations":[95],"available":[96],"Sudan.":[98],"Evaluation":[99],"done":[101],"based":[102],"on":[103],"compendia":[105],"evaluation":[109],"parameters.":[110],"Different":[111],"brands":[112,171,199,216],"5mg":[115],"tablets":[116],"purchased":[117],"randomly":[118],"from":[119],"stores,":[121],"coded":[123],"Z,":[124],"L":[125],"A,":[127],"were":[128,161],"assayed":[129],"for":[130,178,225,362],"weight":[131,179],"uniformity,":[132,180],"friability,":[133,181],"hardness,":[134],"disintegration,":[135],"dissolution":[136,186],"rate":[137],"using":[138,163],"standard":[139,164],"physical":[140],"methods,":[141],"also":[143],"similarity":[145,201],"studied":[147,173],"compare":[149],"brand":[150],"originator":[152],"products.":[156],"Their":[157],"percentage":[158],"contents":[160],"determined":[162],"UV":[165],"Spectrophotometric":[166],"method.":[167],"Results:":[168],"All":[169],"being":[172,217],"comply":[174],"pharmacopoeial":[176,223],"specifications":[177,224],"disintegration":[182],"dissolution.":[184],"profile":[187],"shows":[188],"more":[189],"than":[190],"80":[191],"%":[192],"release":[193],"30":[195],"minutes.":[196],"Additionally,":[197],"all":[198,213,328],"should":[200],"factor":[202],"above":[203],"50%":[204],"therefore":[206],"consider":[209],"as":[210,234],"similar.":[211],"Quantitatively,":[212],"three":[215],"tested":[218],"do":[219],"complied":[220],"with":[221,353,390],"content.":[227],"Conclusion:":[228],"Hence":[229],"will":[232,292,301,330,356,371,380,419],"serve":[233],"tool":[236],"assessing":[238],"monitor":[244],"post":[245],"market":[246],"formulations.":[254],"Peer":[255,431,439],"Review":[256],"History:":[257],"Received":[258,426],"18":[259],"January":[260],"2021;":[261],"Revised":[262],"13":[263],"February;":[264],"Accepted":[265],"3":[266],"March,":[267],"Available":[268],"online":[269],"15":[270],"March":[271],"2021":[272],"UJPR":[273],"follows":[274],"most":[276],"transparent":[277,299],"toughest":[279],"\u2018Advanced":[280],"OPEN":[281],"peer":[282,319,350],"review\u2019":[283],"system.":[284],"identity":[286],"authors":[289,361],"and,":[290],"reviewers":[291,329,408],"known":[294],"each":[296],"other.":[297],"This":[298],"process":[300],"help":[302],"eradicate":[304],"any":[305,310,373],"possible":[306],"malicious/purposeful":[307],"interference":[308],"by":[309,348],"person":[311],"(publishing":[312],"staff,":[313],"reviewer,":[314],"editor,":[315],"author,":[316],"etc)":[317],"review.":[320],"As":[321],"result":[323],"unique":[326],"system,":[327],"get":[331],"due":[333],"recognition":[334],"respect,":[336],"once":[337],"names":[339],"published":[341,354,391],"papers.":[344],"We":[345],"expect":[346],"that,":[347],"publishing":[349],"review":[351,432,440],"reports":[352,388],"papers,":[355],"helpful":[358],"many":[360],"drafting":[363],"article":[365,377],"according":[366,384],"specifications.":[369],"Auhors":[370],"remove":[372],"error":[374],"they":[379],"improve":[381,400],"article(s)":[383],"previous":[387],"displayed":[389],"article(s).":[392],"main":[394],"purpose":[395],"it":[397],"\u2018to":[399],"candidate":[405],"manuscript\u2019.":[406],"Our":[407],"check":[409],"\u2018strength":[411],"weakness":[413],"manuscript":[416],"honestly\u2019.":[417],"There":[418],"increase":[420],"perfection,":[423],"transparency.":[425],"file:":[427],"Reviewer's":[428],"Comments:":[429],"Average":[430,438],"marks":[433,441],"initial":[435],"stage:":[436,444],"5.5/10":[437],"publication":[443],"7.0/10":[445],"Reviewer(s)":[446],"detail:":[447],"Prof.":[448],"Dr.":[449,466,478],"A.":[450],"Hakan":[451],"AKTA\u015e,":[452],"S\u00fcleyman":[453],"Demirel":[454],"University,":[455,474,484],"Faculty":[456],"Science":[458],"Art,":[460],"Department":[461],"Chemistry,":[463],"Isparta-Turkey,":[464],"hakanaktas@sdu.edu.tr":[465],"Vijay":[467],"Kumar":[468],"Singh,":[469],"Institute":[470],"Pharmacy,":[472],"Bundelkhand":[473],"Jhansi,":[475],"India,":[476],"vijayquantum@gmail.com":[477],"Hayriye":[479],"Eda":[480],"\u015eatana":[481],"Kara,":[482],"Gazi":[483],"Turkey,":[485],"eda@gazi.edu.tr":[486],"Similar":[487],"Articles:":[488],"QUALITY":[489,500],"ASSESSMENT":[490,502],"OF":[491,494,503,506],"DIFFERENT":[492,504],"BRANDS":[493,505],"PARACETAMOL":[495],"TABLETS":[496,510],"IN":[497,511],"YEMENI":[498],"MARKET":[499],"CONTROL":[501],"CIPROFLOXACIN":[507],"500":[508],"MG":[509],"YEMEN":[512]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-03-29T00:00:00"}